Purigen Biosystems Raises $18.2M in Series A Financing | GenomeWeb

NEW YORK (GenomeWeb) – Purigen Biosystems said today that it has raised $18.2 million in a Series A financing round, and plans to use the funds to further develop and commercialize its technology for automated preparation of genomic and genetic testing samples.

The round was led by 5AM Ventures and Roche Venture Fund, the company said, with participation from existing investors the Stanford-Startx Fund and Western Investments Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.